Physician profile
Dayton E Dmello
NPI 1699723890
$5,106.83
in general payments reported to CMS, 2019-2025
22 companies · $309 in 2025
The $309 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,462 · 2020: $255 · 2022: $814 · 2023: $836 · 2024: $432 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,481 · Travel and Lodging: $95.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,481.30 |
| Travel and Lodging | $95.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle Biologics, INC | $2,023.36 | 2019 | |
| Glaxosmithkline, LLC. | $1,004.48 | 2019-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Pulmonx Corporation | $472.08 | 2019-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Bayer Healthcare Pharmaceuticals INC. | $269.57 | 2020-2025 | |
| Intuitive Surgical, INC. | $244.46 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $184.34 | 2022-2025 | Tezspire, Airsupra, Fasenra |
| Actelion Pharmaceuticals US, INC. | $171.44 | 2022 | |
| Noah Medical Corporation | $142.18 | 2023 | |
| Inspire Medical Systems, INC. | $115.67 | 2023 | Inspire |
| Grifols USA, LLC | $113.63 | 2019 | |
| Ani Pharmaceuticals, INC. | $74.64 | 2024-2025 | Purified Cortrophin Gel |
| Boston Scientific Corporation | $71.91 | 2022 | |
| Olympus America INC. | $44.93 | 2023 | Spiration Valve System |
| Olympus Corporation of The Americas | $43.86 | 2022 | |
| Ethicon INC. | $24.56 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $23.76 | 2023 | Illumisite |
| Regeneron Healthcare Solutions, INC. | $19.80 | 2024 | Dupixent |
| Pfizer INC. | $14.36 | 2025 | |
| Philips North America LLC | $13.63 | 2025 | Vest Therapy Und |
| Merck Sharp & Dohme LLC | $12.70 | 2019 | |
| Shionogi INC | $12.27 | 2020 | |
| Ambu INC. | $9.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dayton Dmello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.